Literature DB >> 8956153

Control of T lymphocyte signal transduction through clonal anergy.

P Fields1, F W Fitch, T F Gajewski.   

Abstract

Stimulation of interleukin-2 producing T lymphocytes via the T cell receptor (TCR) complex in the absence of other costimulatory factor results paradoxically not in activation but in an unresponsive state termed clonal anergy. T cell anergy appears to be a mechanism by which potentially autoreactive T lymphocytes are inactivated in the periphery, thus maintaining tolerance to self antigens. The breakdown of such tolerance may result in autoimmune diseases. In contrast, induction of peripheral tolerance is the ultimate goal in organ transplantation and is a potential mechanism by which a growing tumor evades immune destruction. The anergic state is characterized by an inability to secrete interleukin-2 and proliferate following restimulation via the TCR even in the presence of constimulatory factors. Recent studies have demonstrated a specific block in Ras activation in anergic T lymphocytes. This defect is correlated with a failure to activate the downstream effectors Erk and Jnk and a lack of activation of the AP-1 transcription factor complex, offering a plausible mechanism for the inability to initiate interleukin-2 gene transcription in the anergic state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956153     DOI: 10.1007/s001090050071

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  8 in total

Review 1.  Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them.

Authors:  Karl John Habashy; Rana Mansour; Charbel Moussalem; Raymond Sawaya; Michel J Massaad
Journal:  Br J Cancer       Date:  2022-06-04       Impact factor: 9.075

2.  An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.

Authors:  Yuanyuan Zha; Thomas F Gajewski
Journal:  Cell Immunol       Date:  2007-09-25       Impact factor: 4.868

3.  Examining T cells at vaccine sites of tumor-bearing hosts provides insights to dysfunctional T-cell immunity.

Authors:  Kristen M Barr; Weiqing Jing; William H D Hallett; Jill A Gershan; Bryon D Johnson
Journal:  J Immunother       Date:  2013-01       Impact factor: 4.456

Review 4.  Molecular regulation of T-cell anergy.

Authors:  Yan Zheng; Yuanyuan Zha; Thomas F Gajewski
Journal:  EMBO Rep       Date:  2008-01       Impact factor: 8.807

5.  DGKα DNA vaccine relieves airway allergic inflammation in asthma model possibly via induction of T cell anergy.

Authors:  Yan Wang; Qiao Zhang; Qianli Ma; Youlan Zhang; Zhiwei Li; Changzheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

6.  Cytokine profile, proliferation and phosphorylation of ERK1/2 and Akt in circulating mononuclear cells from individuals during the chronic intestinal phase of Schistosomiasis mansoni infection.

Authors:  Roberta Oliveira-Prado; Iramaya Rodrigues Caldas; Andréa Teixeira-Carvalho; Marcus Vinicius Andrade; Rafaelle Christine Gomes Fares; Laís Maroni Portugal; Andréa Gazzinelli; Rodrigo Corrêa-Oliveira; José Renan Cunha-Melo
Journal:  BMC Infect Dis       Date:  2012-12-27       Impact factor: 3.090

Review 7.  E3 ubiquitin ligases and their control of T cell autoreactivity.

Authors:  Jody L Bonnevier; Ruan Zhang; Daniel L Mueller
Journal:  Arthritis Res Ther       Date:  2005-10-12       Impact factor: 5.156

8.  Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo.

Authors:  Yan Zheng; Yuanyuan Zha; Gregory Driessens; Frederick Locke; Thomas F Gajewski
Journal:  J Exp Med       Date:  2012-11-05       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.